ArticleOncotarget2016

NT1721, a novel epidithiodiketopiperazine, exhibits potent in vitro and in vivo efficacy against acute myeloid leukemia.

Claudia M Kowolik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.